PDB Short entry for 4NK9 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-NOV-13 4NK9 TITLE CRYSTAL STRUCTURE OF HUMAN FIBROBLAST GROWTH FACTOR RECEPTOR 1 KINASE TITLE 2 DOMAIN IN COMPLEX WITH PYRAZOLAMINOPYRIMIDINE 1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 458-765); COMPND 5 SYNONYM: FGFR-1, BASIC FIBROBLAST GROWTH FACTOR RECEPTOR 1, B BFGF-R- COMPND 6 1, FMS-LIKE TYROSINE KINASE 2, FLT-2, N-SAM, PROTO-ONC FGR; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS KINASE, ATP BINDING, PHOSPHORYLATION, TRANS-MEMBRANE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.A.NORMAN,T.KLEIN REVDAT 3 28-FEB-24 4NK9 1 REMARK SEQADV REVDAT 2 16-JUL-14 4NK9 1 JRNL REVDAT 1 18-DEC-13 4NK9 0 JRNL AUTH T.KLEIN,J.TUCKER,G.A.HOLDGATE,R.A.NORMAN,A.L.BREEZE JRNL TITL FGFR1 KINASE INHIBITORS: CLOSE REGIOISOMERS ADOPT DIVERGENT JRNL TITL 2 BINDING MODES AND DISPLAY DISTINCT BIOPHYSICAL SIGNATURES. JRNL REF ACS MED CHEM LETT V. 5 166 2014 JRNL REFN ISSN 1948-5875 JRNL PMID 24900792 JRNL DOI 10.1021/ML4004205 REMARK 2 REMARK 2 RESOLUTION. 2.57 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 23276 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1197 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.57 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.68 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.75 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2817 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2415 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2664 REMARK 3 BIN R VALUE (WORKING SET) : 0.2388 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.43 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 153 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4232 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 77.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 94.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.99410 REMARK 3 B22 (A**2) : -10.56640 REMARK 3 B33 (A**2) : 3.57230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.53220 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.478 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4464 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6102 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1457 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 92 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 653 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4464 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 569 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4974 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.68 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.29 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|464 - A|765 } REMARK 3 ORIGIN FOR THE GROUP (A): 81.3771 -0.3510 17.7812 REMARK 3 T TENSOR REMARK 3 T11: -0.6634 T22: 0.2522 REMARK 3 T33: -0.7359 T12: 0.1144 REMARK 3 T13: 0.1323 T23: 0.1395 REMARK 3 L TENSOR REMARK 3 L11: 3.3604 L22: 0.5196 REMARK 3 L33: 1.6375 L12: 0.2015 REMARK 3 L13: -0.4882 L23: -0.3136 REMARK 3 S TENSOR REMARK 3 S11: 0.2776 S12: 0.4008 S13: 0.5365 REMARK 3 S21: -0.1814 S22: -0.1202 S23: 0.0187 REMARK 3 S31: -0.2388 S32: 0.0028 S33: -0.1574 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|460 - B|765 } REMARK 3 ORIGIN FOR THE GROUP (A): 34.5618 3.1464 14.4334 REMARK 3 T TENSOR REMARK 3 T11: -0.7291 T22: 0.3170 REMARK 3 T33: -0.7977 T12: 0.1130 REMARK 3 T13: -0.0465 T23: -0.0249 REMARK 3 L TENSOR REMARK 3 L11: 5.4197 L22: 2.0823 REMARK 3 L33: 2.3332 L12: -2.0685 REMARK 3 L13: 0.5619 L23: 0.6399 REMARK 3 S TENSOR REMARK 3 S11: 0.6545 S12: 0.8529 S13: -0.5062 REMARK 3 S21: -0.0777 S22: -0.6667 S23: 0.1834 REMARK 3 S31: 0.2149 S32: 0.2832 S33: 0.0122 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NK9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-13. REMARK 100 THE DEPOSITION ID IS D_1000083308. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23276 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.570 REMARK 200 RESOLUTION RANGE LOW (A) : 42.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.57 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-20% PEG 8000, 100MM PCTP, 200MM REMARK 280 AMMONIUM SULFATE, 25% ETHYLENE GLYCOL, PH 6.75, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 105.17000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.98500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 105.17000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 27.98500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 457 REMARK 465 ALA A 458 REMARK 465 GLY A 459 REMARK 465 VAL A 460 REMARK 465 SER A 461 REMARK 465 GLU A 462 REMARK 465 TYR A 463 REMARK 465 LYS A 502 REMARK 465 GLY A 580 REMARK 465 LEU A 581 REMARK 465 GLU A 582 REMARK 465 TYR A 583 REMARK 465 SER A 584 REMARK 465 TYR A 585 REMARK 465 ASN A 586 REMARK 465 PRO A 587 REMARK 465 SER A 588 REMARK 465 HIS A 589 REMARK 465 ASN A 590 REMARK 465 PRO A 591 REMARK 465 GLU A 592 REMARK 465 LEU A 644 REMARK 465 ALA A 645 REMARK 465 ARG A 646 REMARK 465 ASP A 647 REMARK 465 ILE A 648 REMARK 465 HIS A 649 REMARK 465 HIS A 650 REMARK 465 GLY B 457 REMARK 465 ALA B 458 REMARK 465 GLY B 459 REMARK 465 ASP B 503 REMARK 465 LYS B 504 REMARK 465 GLY B 580 REMARK 465 LEU B 581 REMARK 465 GLU B 582 REMARK 465 TYR B 583 REMARK 465 SER B 584 REMARK 465 TYR B 585 REMARK 465 ASN B 586 REMARK 465 PRO B 587 REMARK 465 SER B 588 REMARK 465 HIS B 589 REMARK 465 ASN B 590 REMARK 465 PRO B 591 REMARK 465 GLU B 592 REMARK 465 GLU B 593 REMARK 465 LEU B 644 REMARK 465 ALA B 645 REMARK 465 ARG B 646 REMARK 465 ASP B 647 REMARK 465 ILE B 648 REMARK 465 HIS B 649 REMARK 465 HIS B 650 REMARK 465 ILE B 651 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 464 CG CD OE1 OE2 REMARK 470 LEU A 465 CG CD1 CD2 REMARK 470 GLU A 467 CG CD OE1 OE2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 PHE A 489 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 491 CG CD OE1 NE2 REMARK 470 ASP A 501 CG OD1 OD2 REMARK 470 ASP A 503 CG OD1 OD2 REMARK 470 LYS A 504 CE NZ REMARK 470 ARG A 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 510 CG CD CE NZ REMARK 470 LEU A 516 CG CD1 CD2 REMARK 470 LYS A 517 CG CD CE NZ REMARK 470 SER A 518 OG REMARK 470 ASP A 519 CG OD1 OD2 REMARK 470 GLU A 522 CG CD OE1 OE2 REMARK 470 LYS A 523 CG CD CE NZ REMARK 470 MET A 534 CE REMARK 470 LYS A 540 CG CD CE NZ REMARK 470 LYS A 542 CE NZ REMARK 470 GLU A 593 CG CD OE1 OE2 REMARK 470 LEU A 595 CD1 CD2 REMARK 470 GLU A 633 CG CD OE1 OE2 REMARK 470 ILE A 651 CG1 CG2 CD1 REMARK 470 LYS A 655 CG CD CE NZ REMARK 470 LYS A 656 CG CD CE NZ REMARK 470 THR A 658 OG1 CG2 REMARK 470 ARG A 675 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 707 CG CD OE1 OE2 REMARK 470 LYS A 711 CG CD CE NZ REMARK 470 LYS A 714 CE NZ REMARK 470 LYS A 748 CG CD CE NZ REMARK 470 LEU A 760 CG CD1 CD2 REMARK 470 GLU A 765 CG CD OE1 OE2 REMARK 470 VAL B 460 CG1 CG2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 464 CG CD OE1 OE2 REMARK 470 ARG B 470 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 477 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 482 CG CD CE NZ REMARK 470 GLU B 486 OE1 OE2 REMARK 470 ILE B 498 CG1 CG2 CD1 REMARK 470 LEU B 500 CG CD1 CD2 REMARK 470 ASP B 501 CG OD1 OD2 REMARK 470 LYS B 502 CE NZ REMARK 470 ASN B 506 CG OD1 ND2 REMARK 470 ARG B 507 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 510 CD CE NZ REMARK 470 LYS B 517 CD CE NZ REMARK 470 GLU B 522 CG CD OE1 OE2 REMARK 470 LYS B 523 CD CE NZ REMARK 470 MET B 534 CE REMARK 470 LYS B 540 CD CE NZ REMARK 470 LEU B 569 CG CD1 CD2 REMARK 470 GLN B 594 CG CD OE1 NE2 REMARK 470 LYS B 598 CG CD CE NZ REMARK 470 LYS B 618 CG CD CE NZ REMARK 470 ILE B 620 CG1 CG2 CD1 REMARK 470 ARG B 622 CD NE CZ NH1 NH2 REMARK 470 GLU B 633 CG CD OE1 OE2 REMARK 470 ILE B 639 CD1 REMARK 470 LYS B 655 CD CE NZ REMARK 470 LYS B 656 CG CD CE NZ REMARK 470 LYS B 714 CG CD CE NZ REMARK 470 LYS B 721 CE NZ REMARK 470 ASN B 724 CG OD1 ND2 REMARK 470 GLU B 728 CG CD OE1 OE2 REMARK 470 MET B 731 CG SD CE REMARK 470 GLN B 743 CG CD OE1 NE2 REMARK 470 LYS B 748 CG CD CE NZ REMARK 470 GLU B 752 OE1 OE2 REMARK 470 LEU B 760 CG CD1 CD2 REMARK 470 ASN B 763 CG OD1 ND2 REMARK 470 GLN B 764 CG CD OE1 NE2 REMARK 470 GLU B 765 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 622 -13.07 77.25 REMARK 500 ASP A 623 44.64 -147.37 REMARK 500 ASP A 641 77.00 39.62 REMARK 500 CYS A 725 118.61 -160.18 REMARK 500 TRP A 737 34.42 -97.62 REMARK 500 SER B 461 -1.04 -59.67 REMARK 500 ASP B 501 -145.84 -98.08 REMARK 500 ARG B 622 -8.06 76.42 REMARK 500 ASP B 623 44.68 -151.15 REMARK 500 PHE B 673 -38.60 -130.99 REMARK 500 TYR B 701 71.98 37.34 REMARK 500 ASN B 724 61.80 62.33 REMARK 500 CYS B 725 118.59 -160.14 REMARK 500 TRP B 737 30.10 -89.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 805 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 806 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2K5 A 807 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2K5 B 802 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F63 RELATED DB: PDB REMARK 900 RELATED ID: 4F64 RELATED DB: PDB REMARK 900 RELATED ID: 4F65 RELATED DB: PDB REMARK 900 RELATED ID: 4NKA RELATED DB: PDB REMARK 900 RELATED ID: 4NKS RELATED DB: PDB DBREF 4NK9 A 458 765 UNP P11362 FGFR1_HUMAN 458 765 DBREF 4NK9 B 458 765 UNP P11362 FGFR1_HUMAN 458 765 SEQADV 4NK9 GLY A 457 UNP P11362 EXPRESSION TAG SEQADV 4NK9 ALA A 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NK9 SER A 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQADV 4NK9 GLY B 457 UNP P11362 EXPRESSION TAG SEQADV 4NK9 ALA B 488 UNP P11362 CYS 488 ENGINEERED MUTATION SEQADV 4NK9 SER B 584 UNP P11362 CYS 584 ENGINEERED MUTATION SEQRES 1 A 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 A 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 A 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 A 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 A 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 A 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 A 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 A 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 A 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 A 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 A 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 A 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 A 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 A 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 A 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 A 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 A 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 A 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 A 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 A 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 A 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 A 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 A 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 A 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU SEQRES 1 B 309 GLY ALA GLY VAL SER GLU TYR GLU LEU PRO GLU ASP PRO SEQRES 2 B 309 ARG TRP GLU LEU PRO ARG ASP ARG LEU VAL LEU GLY LYS SEQRES 3 B 309 PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL LEU ALA SEQRES 4 B 309 GLU ALA ILE GLY LEU ASP LYS ASP LYS PRO ASN ARG VAL SEQRES 5 B 309 THR LYS VAL ALA VAL LYS MET LEU LYS SER ASP ALA THR SEQRES 6 B 309 GLU LYS ASP LEU SER ASP LEU ILE SER GLU MET GLU MET SEQRES 7 B 309 MET LYS MET ILE GLY LYS HIS LYS ASN ILE ILE ASN LEU SEQRES 8 B 309 LEU GLY ALA CYS THR GLN ASP GLY PRO LEU TYR VAL ILE SEQRES 9 B 309 VAL GLU TYR ALA SER LYS GLY ASN LEU ARG GLU TYR LEU SEQRES 10 B 309 GLN ALA ARG ARG PRO PRO GLY LEU GLU TYR SER TYR ASN SEQRES 11 B 309 PRO SER HIS ASN PRO GLU GLU GLN LEU SER SER LYS ASP SEQRES 12 B 309 LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET GLU SEQRES 13 B 309 TYR LEU ALA SER LYS LYS CYS ILE HIS ARG ASP LEU ALA SEQRES 14 B 309 ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET LYS SEQRES 15 B 309 ILE ALA ASP PHE GLY LEU ALA ARG ASP ILE HIS HIS ILE SEQRES 16 B 309 ASP TYR TYR LYS LYS THR THR ASN GLY ARG LEU PRO VAL SEQRES 17 B 309 LYS TRP MET ALA PRO GLU ALA LEU PHE ASP ARG ILE TYR SEQRES 18 B 309 THR HIS GLN SER ASP VAL TRP SER PHE GLY VAL LEU LEU SEQRES 19 B 309 TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO GLY SEQRES 20 B 309 VAL PRO VAL GLU GLU LEU PHE LYS LEU LEU LYS GLU GLY SEQRES 21 B 309 HIS ARG MET ASP LYS PRO SER ASN CYS THR ASN GLU LEU SEQRES 22 B 309 TYR MET MET MET ARG ASP CYS TRP HIS ALA VAL PRO SER SEQRES 23 B 309 GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ASP LEU ASP SEQRES 24 B 309 ARG ILE VAL ALA LEU THR SER ASN GLN GLU HET EDO A 801 4 HET EDO A 802 4 HET EDO A 803 4 HET EDO A 804 4 HET SO4 A 805 5 HET SO4 A 806 5 HET 2K5 A 807 32 HET SO4 B 801 5 HET 2K5 B 802 32 HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETNAM 2K5 N~4~-{5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-3- HETNAM 2 2K5 YL}-N~2~-[(3-METHYL-1,2-OXAZOL-5-YL)METHYL]PYRIMIDINE- HETNAM 3 2K5 2,4-DIAMINE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 4(C2 H6 O2) FORMUL 7 SO4 3(O4 S 2-) FORMUL 9 2K5 2(C22 H25 N7 O3) FORMUL 12 HOH *85(H2 O) HELIX 1 1 PRO A 474 ASP A 476 5 3 HELIX 2 2 THR A 521 GLY A 539 1 19 HELIX 3 3 ASN A 568 ARG A 576 1 9 HELIX 4 4 SER A 596 LYS A 617 1 22 HELIX 5 5 ALA A 625 ARG A 627 5 3 HELIX 6 6 LEU A 662 MET A 667 5 6 HELIX 7 7 ALA A 668 ASP A 674 1 7 HELIX 8 8 THR A 678 THR A 695 1 18 HELIX 9 9 PRO A 705 GLU A 715 1 11 HELIX 10 10 THR A 726 TRP A 737 1 12 HELIX 11 11 VAL A 740 ARG A 744 5 5 HELIX 12 12 THR A 746 THR A 761 1 16 HELIX 13 13 PRO B 474 ASP B 476 5 3 HELIX 14 14 THR B 521 GLY B 539 1 19 HELIX 15 15 ASN B 568 ARG B 576 1 9 HELIX 16 16 SER B 596 LYS B 617 1 22 HELIX 17 17 ALA B 625 ARG B 627 5 3 HELIX 18 18 LEU B 662 MET B 667 5 6 HELIX 19 19 ALA B 668 ASP B 674 1 7 HELIX 20 20 THR B 678 THR B 695 1 18 HELIX 21 21 PRO B 705 GLU B 715 1 11 HELIX 22 22 THR B 726 TRP B 737 1 12 HELIX 23 23 VAL B 740 ARG B 744 5 5 HELIX 24 24 THR B 746 THR B 761 1 16 SHEET 1 A 5 LEU A 478 GLU A 486 0 SHEET 2 A 5 GLN A 491 ILE A 498 -1 O LEU A 494 N GLY A 481 SHEET 3 A 5 VAL A 508 MET A 515 -1 O THR A 509 N ALA A 497 SHEET 4 A 5 TYR A 558 VAL A 561 -1 O VAL A 561 N ALA A 512 SHEET 5 A 5 LEU A 547 CYS A 551 -1 N LEU A 548 O ILE A 560 SHEET 1 B 2 VAL A 629 VAL A 631 0 SHEET 2 B 2 MET A 637 ILE A 639 -1 O LYS A 638 N LEU A 630 SHEET 1 C 5 LEU B 478 GLU B 486 0 SHEET 2 C 5 GLN B 491 ILE B 498 -1 O LEU B 494 N GLY B 481 SHEET 3 C 5 VAL B 508 MET B 515 -1 O VAL B 513 N VAL B 493 SHEET 4 C 5 TYR B 558 VAL B 561 -1 O VAL B 561 N ALA B 512 SHEET 5 C 5 LEU B 547 CYS B 551 -1 N LEU B 548 O ILE B 560 SHEET 1 D 2 VAL B 629 VAL B 631 0 SHEET 2 D 2 MET B 637 ILE B 639 -1 O LYS B 638 N LEU B 630 CISPEP 1 ASP A 503 LYS A 504 0 3.41 SITE 1 AC1 4 TYR A 701 ARG A 718 MET A 719 TRP A 737 SITE 1 AC2 4 THR A 746 PHE A 747 LYS A 748 HOH A 903 SITE 1 AC3 3 ARG A 470 LYS A 618 HIS A 679 SITE 1 AC4 3 ARG A 577 SER A 699 HOH A 908 SITE 1 AC5 3 GLY A 539 LYS A 540 LYS A 618 SITE 1 AC6 6 ARG A 570 ARG A 627 THR A 657 ASN A 659 SITE 2 AC6 6 ARG A 661 HOH A 905 SITE 1 AC7 17 LEU A 484 GLY A 485 GLU A 486 GLY A 487 SITE 2 AC7 17 VAL A 492 ALA A 512 LYS A 514 GLU A 531 SITE 3 AC7 17 ILE A 545 VAL A 561 GLU A 562 ALA A 564 SITE 4 AC7 17 GLY A 567 LEU A 630 ASP A 641 PHE A 642 SITE 5 AC7 17 HOH A 946 SITE 1 AC8 6 ARG B 570 ARG B 627 THR B 657 ASN B 659 SITE 2 AC8 6 ARG B 661 HOH B 934 SITE 1 AC9 12 LEU B 484 VAL B 492 ALA B 512 LYS B 514 SITE 2 AC9 12 GLU B 531 ILE B 545 VAL B 561 GLU B 562 SITE 3 AC9 12 ALA B 564 ASP B 641 PHE B 642 HOH B 935 CRYST1 210.340 55.970 65.720 90.00 107.43 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004754 0.000000 0.001493 0.00000 SCALE2 0.000000 0.017867 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015948 0.00000